Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Opticyte Inc. is currently addressing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are being handled by 2 distinct examiners, which indicates that each pending matter has a unique reviewer. Despite the involvement of the distinct examiners, all prosecution activity is centralized within 1 distinct art unit. This concentration in 1 art unit suggests that the underlying technology falls within a specific niche of medical or mechanical engineering.
MONTGOMERY, MELISSA JO is the busiest examiner for this portfolio, with 1 pending office action currently assigned. Given that there are the pending office actions and 2 distinct examiners, the workload is evenly split. The presence of 1 distinct art unit for both actions may provide some consistency in the general examination guidelines applied to the matters. Practitioners must manage the expectations of 2 distinct examiners while operating within the procedural framework of a single art unit. This focus on 1 distinct art unit simplifies the administrative burden.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTGOMERY, MELISSA JO | 1 | 14.8% | +40.0% |
| PYLE, SIENNA CHRISTINE | 1 | 72.2% | +16.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18991196 | Determining Blood-Oxygen Level (SpO2) Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SpO2 Value, And/Or Using Broadband Spectra to Determine Pulse Rate | MONTGOMERY, MELISSA JO | — |
| 17721167 | DETERMINING A LEVEL OF OXYGENATION OF ONE OR MORE CELLS | PYLE, SIENNA CHRISTINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18991196 | Determining Blood-Oxygen Level (SpO2) Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SpO2 Value, And/Or Using Broadband Spectra to Determine Pulse Rate | MONTGOMERY, MELISSA JO | — |
| 17721167 | DETERMINING A LEVEL OF OXYGENATION OF ONE OR MORE CELLS | PYLE, SIENNA CHRISTINE | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18991196 | Determining Blood-Oxygen Level (SpO2) Using Broadband Spectra To Reduce Or Eliminate Skin-Tone Bias In The Determined SpO2 Value, And/Or Using Broadband Spectra to Determine Pulse Rate | MONTGOMERY, MELISSA JO | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 17721167 | DETERMINING A LEVEL OF OXYGENATION OF ONE OR MORE CELLS | PYLE, SIENNA CHRISTINE | 3791 | §103§112 | Final Rejection | — | Pending | Apr 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOpticyte Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Melissa Jo Montgomery has the most, with 1 of Opticyte Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
